Background In current international guidelines, intraaortic balloon counterpulsation is
considered to be a class I treatment for cardiogenic shock complicating acute myocardial …

BACKGROUND: In current guidelines, intraaortic balloon pumping (IABP) is considered a
class 1 indication in cardiogenic shock complicating acute myocardial infarction. However …

Background In current international guidelines the recommendation for intra-aortic balloon
pump (IABP) use has been downgraded in cardiogenic shock complicating acute …

Background: The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is
still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial …

Background Cardiogenic shock complicating acute myocardial infarction (AMI) remains the
leading cause of death in patients hospitalized with AMI. Although several studies have …

We conducted the IABP Cardiogenic Shock Trial (ClinicalTrials. gov ID NCT00469248) as a
prospective, randomized, monocentric clinical trial to determine the hemodynamic effects of …

Primary percutaneous coronary intervention (PCI) and intra-aortic balloon pump
counterpulsation (IABP) are established treatment modalities in acute myocardial infarction …

Objectives. We sought to examine the use, complications and outcomes with early intraaortic
balloon counterpulsation (IABP) in patients presenting with cardiogenic shock complicating …

Objectives: We sought to examine contemporary utilization patterns and clinical outcomes in
patients with acute myocardial infarction (AMI) requiring intra-aortic balloon pump (IABP) …

Background Intra‐aortic balloon pump counterpulsation (IABP) is currently the most
commonly used mechanical assist device for patients with cardiogenic shock due to acute …